文献速递鼻科

Chitogel在内镜鼻窦手术后促进健康微生物组并减少术后感染

Chitogel following endoscopic sinus surgery promotes a healthy microbiome and reduces postoperative infections.
PubMed 文献 · Int Forum Allergy Rhinol · 2022-04-07

这项双盲随机对照试验前瞻性纳入25例接受内镜鼻窦手术的患者,术中在一侧鼻窦使用Chitogel、对侧作为对照。结果显示Chitogel侧术后12周内镜外观和窦口通畅度改善,感染率降低(12.0% vs 52.0%),共生菌相对丰度增加。

要点

  • Chitogel侧术后12周感染率为12.0%,对照侧为52.0%(p=0.005)。
  • Chitogel侧内镜外观改善(p=0.03),窦口通畅度优于对照侧(p<0.001)。
  • Chitogel侧棒状杆菌和Cutibacterium(丙酸杆菌)合并相对丰度从基线30.15%升至12周46.62%,对照侧从47.18%降至40.79%(p.adj=0.01)。

核心结论

  • Chitogel显著改善术后12周鼻窦内镜外观和窦口通畅度。
  • Chitogel使用后有助于恢复更健康的微生物组,增加共生菌棒状杆菌和Cutibacterium(丙酸杆菌)的相对丰度。
  • Chitogel使用后术后感染显著减少。

研究设计与样本

  • 双盲随机对照试验,前瞻性纳入25例接受内镜鼻窦手术的患者。
  • 术中随机将Chitogel应用于一侧鼻窦,另一侧作为对照。
  • 术后2、6、12周进行鼻内镜随访,术中及术后12周采集双侧鼻窦微生物学和微生物组拭子,出现感染时额外采集拭子。

主要发现

  • 术后12周Chitogel侧内镜外观改善(p=0.03),窦口通畅度优于对照侧(p<0.001)。
  • Chitogel侧感染率为12.0%,对照侧为52.0%,差异显著(p=0.005)。
  • Chitogel侧棒状杆菌和Cutibacterium(丙酸杆菌)合并相对丰度从基线30.15%升至12周46.62%,对照侧从47.18%降至40.79%(p.adj=0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative infections following endoscopic sinus surgery (ESS) impair wound healing and lead to poor outcomes. The aim of this study is to assess the effectiveness of Chitogel to reduce postoperative infections and restore a healthy microbiome following ESS. METHODS: In this double-blinded randomized control trial, 25 patients undergoing ESS were prospectively recruited. At the end of surgery, patients were randomized to receive Chitogel to one side of the sinuses (allowing the other side to serve as control). Patients underwent routine follow-up with nasoendoscopies performed at 2, 6, and 12 weeks postoperatively. Sinus ostial measurements, microbiology, and microbiome swabs from bilateral sides were collected intraoperatively and at 12 weeks postoperatively. Additional swabs were collected if infection was present. RESULTS: Improved endoscopic appearance of the sinuses (p = 0.03) and ostial patency were noted on the Chitogel side compared with control at 12 weeks (p < 0.001). A significant decrease in infections on the Chitogel side (12.0%) compared with control (52.0%) (p = 0.005) was evident. Following the use of Chitogel, there was a significant increase in the combined relative abundance of commensals Corynebacterium and Cutibacterium (Propionibacterium) from 30.15% at baseline to 46.62% at 12 weeks compared with control (47.18% to 40.79%) (p.adj = 0.01). CONCLUSION: Chitogel significantly improved both the nasoendoscopic appearance of the sinuses and sinus ostial patency at 12 weeks postoperatively. Chitogel used following ESS helps restore an improved microbiome resulting in an increase in the relative abundance of commensals Corynebacterium and Cutibacterium (Propionibacterium). A significant decrease in postoperative infections was noted following use of Chitogel.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Megow A, Alsuliman Y, Bouras G, et al. Chitogel following endoscopic sinus surgery promotes a healthy microbiome and reduces postoperative infections. Int Forum Allergy Rhinol. 2022. PMID: 35319832. doi:10.1002/alr.23001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。